[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
Mazurkova NA, Ryndiuk NN, Shishkina LN, Ternovoĭ VA, Tumanov IuV, Bulychev LE, Skarnovich MO, Kabanov AS, Panchenko SG, Aleĭnikov RP, Il'ina TN, Kuzubov VI, Mel'nikov SIa, Mironov AN, Korovkin SA, Sergeev AN, Drozdov IG.
Mazurkova NA, et al. Among authors: mironov an.
Vestn Ross Akad Med Nauk. 2010;(3):15-20.
Vestn Ross Akad Med Nauk. 2010.
PMID: 20422755
Clinical Trial.
Russian.